3/7
12:10 pm
avir
Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) had its "outperform" rating re-affirmed by analysts at William Blair.
3/6
06:16 pm
avir
https://seekingalpha.com/article/4765490-atea-pharmaceuticals-inc-avir-q4-2024-earnings-call-transcript [Seeking Alpha]
Low
Report
https://seekingalpha.com/article/4765490-atea-pharmaceuticals-inc-avir-q4-2024-earnings-call-transcript [Seeking Alpha]
3/6
05:21 pm
avir
Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Low
Report
Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
3/6
04:05 pm
avir
Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Low
Report
Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
2/27
07:00 am
avir
Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on March 6, 2025
Medium
Report
Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on March 6, 2025
2/24
08:04 am
avir
Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors [Yahoo! Finance]
Medium
Report
Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors [Yahoo! Finance]
2/24
07:00 am
avir
Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors
Medium
Report
Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors
1/13
07:00 am
avir
Atea Pharmaceuticals to Highlight 2025 Strategic Priorities at the 43rd Annual J.P. Morgan Healthcare Conference
Low
Report
Atea Pharmaceuticals to Highlight 2025 Strategic Priorities at the 43rd Annual J.P. Morgan Healthcare Conference
1/8
07:00 am
avir
Atea Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Low
Report
Atea Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
12/18
05:05 pm
avir
Concerned Shareholder Group Calls for Atea Pharmaceuticals to Appoint a New, Shareholder-Oriented Lead Independent Director to Oversee Strategic Review Process
Low
Report
Concerned Shareholder Group Calls for Atea Pharmaceuticals to Appoint a New, Shareholder-Oriented Lead Independent Director to Oversee Strategic Review Process
12/16
05:00 am
avir
Atea Pharmaceuticals Retains Financial Advisor to Explore Strategic Partnerships
Medium
Report
Atea Pharmaceuticals Retains Financial Advisor to Explore Strategic Partnerships